ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134459; 2) Community: the network communities that were significantly associated with the response to NSC 134459; 3) Molecule: the relationships between components within communities and NSC 134459; 4) MDR: the compounds that were significantly associated with the NSC 134459.

NSC Compound Enrichment Correlation
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0048681766467277 0.27144071
NSC 641151 1,2-Dimethyl-phenothiazone 0.0048681766467277 0.2933712
NSC 645431 1H-Benz[g]indol-5-ol, 2-phenyl 0.0048681766467277 0.1930962
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.0048681766467277 0.16055236
NSC 656208 Null 0.0048681766467277 0.21334377
NSC 670329 Null 0.0048681766467277 0.32593805
NSC 681637 Camptothecin Derivative 0.0048681766467277 0.58492333
NSC 684569 Barbituric acid, 5-[3-(4-methoxyphenyl)- 2-propenylidene]-2-thio- 0.0048681766467277 0.30967768
NSC 700892 Pinnatin B 0.0048681766467277 0.2474738
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0048681766467277 0.44615811
Total:128  Current:27    [First] [Prev] [Next] [Last]